A proposal for a psychopharmacology–pharmacotherapy catalogue of learning objectives and a curriculum in Europe

References

• Aigner M, Treasure J, Kaye W, Kasper S. 2011. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry. 12:400–443.
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Kosky N. 2007. Off-label prescribing in psychiatric practice. Advances in Psychiatric Treatment. 13:414–422.
   Google Scholar
• Balon R. 2005. Teaching psychopharmacology: introduction. Acad Psychiatry. 29:116–119.
   PubMed Web of Science ®Google Scholar
• Blanco C, Lujan JJ, Nunes EV. 2005. Education and training in psychopharmacology. Acad Psychiatry. 29:124–127.
   PubMed Web of Science ®Google Scholar
• Blier P. 2014. Rational site-directed pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol. 17:997–1008.
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U, Baumann P, Müller H, Müller-Oerlinghausen B, Poser B, Rommelspacher H, et al. 1995a. The Association of Neuropsychopharmacology and Pharmacopsychiatry (AGNP): proposed issues for a residency's training in psychopharmacology (part 1). Pharmacopsychiatry. 28:108–112.
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U, Baumann P, Müller H, Müller-Oerlinghausen B, Poser B, Rommelspacher H, et al. 1995b. The Association of Neuropsychopharmacology and Pharmacopsychiatry (AGNP): proposed issues for a residency's training in psychopharmacology (part 2). Pharmacopsychiatry. 28:153–157.
   Web of Science ®Google Scholar
• Buckley PF, Miller BJ, Lehrer DS, Castle DJ. 2009. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 35:383–402.
   PubMed Web of Science ®Google Scholar
• Cullinan S, O'Mahony D, Fleming A, Byrne S. 2014. A meta-synthesis of potentially inappropriate prescribing in older patients. Drugs Aging. 31:631–638.
   PubMed Web of Science ®Google Scholar
• Deligiannidis KM, Girgis RR, Lau A, Balon R, Zisook S. 2012. Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression. Acad Psychiatry. 36:414–418.
   PubMed Web of Science ®Google Scholar
• Diaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C. 2014. Polypharmacy with antidepressants in children and adolescents. Int J Neuropsychopharmacol. 17:1063–1082.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL. 2005. Who is teaching psychopharmacology? Who should be teaching psychopharmacology? Acad Psychiatry. 29:155–161.
   PubMed Web of Science ®Google Scholar
• Ellison JM. 2005. Teaching collaboration between pharmacotherapist and psychotherapist. Acad Psychiatry. 29:195–202.
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Uchida H. 2014. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int J Neuropsychopharmacol. 17:1083–1093.
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Moller HJ. 2011. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol. 14:405–412.
   PubMed Web of Science ®Google Scholar
• Georgiopoulos AM, Huffman JC. 2005. Teaching psychopharmacology: two trainees' perspectives. Acad Psychiatry. 29:167–175.
   PubMed Web of Science ®Google Scholar
• Glick I, Balon R, Citrome L, Deligiannidis K, Ellison J, Madaan V, et al. 2014. Model psychopharmacology curriculum. For training directors and teachers of psychopharmacology in psychiatric residency programs. (8th edition). Brentwood (TN): The American Society of Clinical Psychopharmacology Inc.
   Google Scholar
• Glick ID, Zisook S. 2005. The challenge of teaching psychopharmacology in the new millennium: the role of curricula. Acad Psychiatry. 29:134–140.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. 2013. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 14:154–219.
   PubMed Web of Science ®Google Scholar
• Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller H-J, WFSBP Task Force on Treatment Guidelines for Schizophrenia. 2012. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 13:318–378.
   PubMed Web of Science ®Google Scholar
• Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller H-J, WFSBP Task Force on Treatment Guidelines for Schizophrenia. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 14:2–44.
   PubMed Web of Science ®Google Scholar
• Haueis P, Greil W, Huber M, Grohmann R, Kullak-Ublick GA, Russmann S. 2011. Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software. Clin Pharmacol Ther. 90:588–596.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, et al. 2011. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011. Pharmacopsychiatry. 44:195–235.
   Web of Science ®Google Scholar
• Ito H, Yamazumi S. 2003. Common types of medication errors on long-term psychiatric care units. Int J Qual Health Care. 15:207–212.
   PubMed Web of Science ®Google Scholar
• Jayaram G, Doyle D, Steinwachs D, Samuels J. 2011. Identifying and reducing medication errors in psychiatry: creating a culture of safety through the use of an adverse event reporting mechanism. J Psychiatr Pract. 17:81–88.
   PubMed Web of Science ®Google Scholar
• Jefferson JW. 2005. Old versus new medications: how much should be taught? Acad Psychiatry. 29:162–166.
   PubMed Web of Science ®Google Scholar
• Jibson MD. 2005. Psychopharmacology training in psychiatric education: the debate. Acad Psychiatry. 29:120–123.
   PubMed Web of Science ®Google Scholar
• Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University. 2014. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 14(Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Keijsers CJ, van Hensbergen L, Jacobs L, Brouwers JR, de Wildt DJ, ten Cate OT, et al. 2012. Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Br J Clin Pharmacol. 74:762–773.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, et al. 2004. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry Psychiatry. 9:442–473.
   PubMed Web of Science ®Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 5:e45.
   PubMed Web of Science ®Google Scholar
• Kontos N, Querques J, Freudenreich O. 2006. The problem of the psychopharmacologist. Acad Psychiatry. 30:218–226.
   PubMed Web of Science ®Google Scholar
• Laux G. 2014. Proposal for a model psychopharmacology curriculum for psychiatric residents in Germany. Psychopharmakotherapie. 21:64–68.
   Google Scholar
• Likic R, Maxwell SR. 2009. Prevention of medication errors: teaching and training. Br J Clin Pharmacol. 67:656–661.
   PubMed Web of Science ®Google Scholar
• Lotz-Rambaldi W, Schafer I, ten Doesschate R, Hohagen F. 2008. Specialist training in psychiatry in Europe-results of the UEMS-survey. Eur Psychiatry. 23:157–168.
   PubMed Web of Science ®Google Scholar
• Louie A, Roberts LW, Coverdale J. 2005. Imparting the knowledge, science, and art of psychopharmacology: thoughts on educational research questions. Acad Psychiatry. 29:113–115.
   PubMed Web of Science ®Google Scholar
• Mann K, Rothschild JM, Keohane CA, Chu JA, Bates DW. 2008. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry. 9:24–33.
   PubMed Web of Science ®Google Scholar
• Mayer S, van der Gaag RJ, Dom G, Wassermann D, Gaebel W, Falkai P, et al. 2014. European Psychiatric Association (EPA) guidance on post-graduate psychiatric training in Europe. Eur Psychiatry. 29:101–106.
   PubMed Web of Science ®Google Scholar
• Members of EMERGE, the Erice Medication Errors Research Group, Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialova D, Fitzgerald RJ, Likić R, Maxwell SR, et al. 2009. Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol. 67:592–598.
   Google Scholar
• Millan MJ. 2014. On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal. Int J Neuropsychopharmacol. 17:1009–1037.
   PubMed Web of Science ®Google Scholar
• Mintz DL. 2005. Teaching the prescriber's role: the psychology of psychopharmacology. Acad Psychiatry. 29:187–194.
   PubMed Web of Science ®Google Scholar
• Mohr P, Hoschl C, Volavka J. 2012. Teaching critical appraisal of articles on psychopharmacology. Acad Psychiatry. 36:114–117.
   PubMed Web of Science ®Google Scholar
• Moller HJ, Seemuller F, Schennach-Wolff R, Stubner S, Ruther E, Grohmann R. 2014. History, background, concepts and current use of comedication and polypharmacy in psychiatry. Int J Neuropsychopharmacol. 17:983–996.
   PubMed Web of Science ®Google Scholar
• Naber D, Hohagen F. 2008. Training in psychiatry and psychotherapy in Germany. Encephale. 34:107–109.
   PubMed Web of Science ®Google Scholar
• Osser DN, Patterson RD, Levitt JJ. 2005. Guidelines, algorithms, and evidence-based psychopharmacology training for psychiatric residents. Acad Psychiatry. 29:180–186.
   PubMed Web of Science ®Google Scholar
• Peglow S, Spiegel D, Memon H, Briscoe G. 2014. Big pharma in residency training: losing more than a free lunch? Acad Psychiatry. 38:516–517.
   PubMed Web of Science ®Google Scholar
• Prabhakar D, Balon R, Zisook S. 2012. Assessing the need for a multi-modal curriculum in psychopharmacology education. Acad Psychiatry. 36:497–499.
   PubMed Web of Science ®Google Scholar
• Rakofsky JJ, Dunlop BW. 2012. US psychiatric residents' treatment of patients with bipolar disorder. J Clin Psychopharmacol. 32:231–236.
   PubMed Web of Science ®Google Scholar
• Riese F, Guloksuz S, Roventa C, Fair JD, Haravuori H, Rolko T, et al. 2015. Pharmaceutical industry interactions of psychiatric trainees from 20 European countries. Eur Psychiatry. 30:284–290.
   PubMed Web of Science ®Google Scholar
• Salzman C. 2005. The limited role of expert guidelines in teaching psychopharmacology. Acad Psychiatry. 29:176–179.
   PubMed Web of Science ®Google Scholar
• Soerensen AL, Lisby M, Nielsen LP, Poulsen BK, Mainz J. 2013. The medication process in a psychiatric hospital: are errors a potential threat to patient safety? Risk Manag Healthc Policy. 6:23–31.
   PubMedGoogle Scholar
• Weiden PJ, Rao N. 2005. Teaching medication compliance to psychiatric residents: placing an orphan topic into a training curriculum. Acad Psychiatry. 29:203–210.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. 2013. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 15:1–44.
   PubMed Web of Science ®Google Scholar
• Zisook S, Balon R, Benjamin S, Beresin E, Goldberg DA, Jibson MD, et al. 2009. Psychopharmacology curriculum field test. Acad Psychiatry. 33:358–363.
   PubMed Web of Science ®Google Scholar
• Zisook S, Benjamin S, Balon R, Glick I, Louie A, Moutier C, et al. 2005. Alternate methods of teaching psychopharmacology. Acad Psychiatry. 29:141–154.
   PubMed Web of Science ®Google Scholar
• Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM. 2014a. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 24:1005–1014.
   PubMed Web of Science ®Google Scholar
• Zohar J, Stahl B, Möller HJ, Blier P, Kupfer D, Yamawaki S, Uchida C, Spedding M, Goodwin G, Nutt D. 2014b. NbNomenclature. Neuroscience based nomenclature. Cambridge (UK): Cambridge University Press.
   Google Scholar